Numinus Wellness Inc. (OTCMKTS:NUMIF – Get Rating) was the recipient of a large decline in short interest during the month of December. As of December 30th, there was short interest totalling 236,600 shares, a decline of 28.8% from the December 15th total of 332,200 shares. Based on an average daily trading volume, of 421,200 shares, the days-to-cover ratio is currently 0.6 days.
Wall Street Analyst Weigh In
Separately, Maxim Group initiated coverage on Numinus Wellness in a research note on Thursday, December 8th. They set a "positive" rating and a $0.50 price target on the stock.
Get
Numinus Wellness alerts:
Numinus Wellness Price Performance
Shares of NUMIF stock remained flat at C$0.21 on Friday. The stock had a trading volume of 62,783 shares, compared to its average volume of 124,483. Numinus Wellness has a fifty-two week low of C$0.11 and a fifty-two week high of C$0.65.
About Numinus Wellness
(Get Rating)
Numinus Wellness Inc provides solutions to develop and deliver psychedelic-assisted psychotherapy and transform the mental health. The company operates through three segments: Research Operations, Canadian Clinic Network, and U.S Clinic Network. The Research Operations segment offers laboratory services, such as cultivation, analytical testing, product research and development, and ancillary services in the area of psychedelics.
Featured Articles
- Get a free copy of the StockNews.com research report on Numinus Wellness (NUMIF)
- MarketBeat Week in Review – 1/16 – 1/20
- Does Old Dominion Show That Trucking Is Hitting The Brakes?
- Nordstrom Puts Fear Of Markdowns Into Retail Sector
- Exxon Mobil Stock: Within Striking Distance Of Buy Point
- High-Dividend-Yielding BHP Sees China Driving '23 Growth
Receive News & Ratings for Numinus Wellness Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Numinus Wellness and related companies with MarketBeat.com's FREE daily email newsletter.
納米納斯健康公司(OTCMKTS：NUMIF-GET Rating)是空頭股數12月份股價大幅下跌的接收方。截至12月30日，空頭股數共有236,600股，較12月15日的332,200股下降28.8%。以日均成交量421,200股計算，目前天數與回補比率為0.6天。
華爾街分析師也加入進來
另外，Maxim Group在12月8日星期四的一份研究報告中發起了對努米納斯健康的報道。他們為該股設定了“正面”評級和0.50美元的目標價。
到達
努米諾斯健康警報：
紐米諾健康性價比
週五，NUMIF的股票持平於0.21加元。該股成交量為62,783股，而其平均成交量為124,483股。Nnuus Wellness的52周低點為0.11加元，52周高位為0.65加元。
關於努米諾斯的健康
(獲取評級)
努米納斯健康公司提供解決方案，以開發和提供迷幻輔助心理治療，並改變心理健康。該公司通過三個部門運營：研究運營、加拿大臨床網路和美國臨床網路。研究運營部門提供實驗室服務，如種植、分析測試、產品研究和開發，以及迷幻藥領域的輔助服務。
專題文章
- 免費獲取StockNews.com關於努米納斯健康的研究報告(NUMIF)
- 市場回顧周-1/16-1/20
- Old Dominion是否表明Trucking正在踩剎車？
- 諾德斯特龍對零售業降價的擔憂
- 埃克森美孚股票：在Buy Point附近
- 高股息率的必和必拓認為中國推動了23年的增長
接受《努米納斯健康日報》的新聞和評級-在下面輸入您的電子郵件地址，即可通過MarketBeat.com的免費每日電子郵件時事通訊，獲得對努米納斯健康和相關公司的最新新聞和分析師評級的每日簡要摘要。
